Differential xenobiotic induction of CYP2A5 in mouse liver, kidney, lung, and olfactory mucosa

Ting Su, Wenlei He, Jun Gu, Thomas W. Lipinskas, Xinxin Ding

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The effects of pyrazole, which is known to induce hepatic cytochrome P4502A5 (CYP2AS) through posttranscriptional mechanisms, on the level of CYP2A5 in liver and extrahepatic tissues were examined in this study. Intraperitoneal administration of pyrazole at 200 mg/kg for 3 days induced CYP2A4/5 mRNAs and proteins and microsomal coumarin 7-hydroxylation activity in liver and kidney of C57BL/6 mice. A marginal increase (30%) in CYP2A4/5 mRNAs was also observed in the olfactory mucosa but not in the lung, and no increase in CYP2A4/5 proteins or microsomal coumarin 7-hydroxylation activity was observed in either the olfactory mucosa or lung. CYP2A4/5 proteins were not detected on immunoblots in other tissues examined, including breast, bone marrow, testis, prostate, ovary, and uterus from control or pyrazole-treated mice. On the other hand, pyrazole treatment induced CYP2E1 in the olfactory mucosa as well as in liver and kidney, indicating that the olfactory mucosa was exposed to pyrazole. The lack of CYP2A inducibility in the olfactory mucosa was also observed for several other known inducers of hepatic CYP2A5, including cobaltous chloride, stannous chloride, griseofulvin, thioacetamide, and aminotriazole. These results suggest that the mechanisms involved in the induction of hepatic and renal CYP2A5 by pyrazole and other xenobiotic compounds may be tissue-specific.

Original languageEnglish (US)
Pages (from-to)822-824
Number of pages3
JournalDrug Metabolism and Disposition
Volume26
Issue number8
StatePublished - Aug 1 1998
Externally publishedYes

Fingerprint

Olfactory Mucosa
Xenobiotics
Kidney
Lung
Liver
Hydroxylation
Amitrole
Thioacetamide
Griseofulvin
Cytochrome P-450 CYP2E1
Messenger RNA
Proteins
Cytochromes
Inbred C57BL Mouse
Uterus
pyrazole
Testis
Prostate
Ovary
Breast

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Differential xenobiotic induction of CYP2A5 in mouse liver, kidney, lung, and olfactory mucosa. / Su, Ting; He, Wenlei; Gu, Jun; Lipinskas, Thomas W.; Ding, Xinxin.

In: Drug Metabolism and Disposition, Vol. 26, No. 8, 01.08.1998, p. 822-824.

Research output: Contribution to journalArticle

Su, Ting ; He, Wenlei ; Gu, Jun ; Lipinskas, Thomas W. ; Ding, Xinxin. / Differential xenobiotic induction of CYP2A5 in mouse liver, kidney, lung, and olfactory mucosa. In: Drug Metabolism and Disposition. 1998 ; Vol. 26, No. 8. pp. 822-824.
@article{fd86ae5f4e1141d988a74a4ead9b770c,
title = "Differential xenobiotic induction of CYP2A5 in mouse liver, kidney, lung, and olfactory mucosa",
abstract = "The effects of pyrazole, which is known to induce hepatic cytochrome P4502A5 (CYP2AS) through posttranscriptional mechanisms, on the level of CYP2A5 in liver and extrahepatic tissues were examined in this study. Intraperitoneal administration of pyrazole at 200 mg/kg for 3 days induced CYP2A4/5 mRNAs and proteins and microsomal coumarin 7-hydroxylation activity in liver and kidney of C57BL/6 mice. A marginal increase (30{\%}) in CYP2A4/5 mRNAs was also observed in the olfactory mucosa but not in the lung, and no increase in CYP2A4/5 proteins or microsomal coumarin 7-hydroxylation activity was observed in either the olfactory mucosa or lung. CYP2A4/5 proteins were not detected on immunoblots in other tissues examined, including breast, bone marrow, testis, prostate, ovary, and uterus from control or pyrazole-treated mice. On the other hand, pyrazole treatment induced CYP2E1 in the olfactory mucosa as well as in liver and kidney, indicating that the olfactory mucosa was exposed to pyrazole. The lack of CYP2A inducibility in the olfactory mucosa was also observed for several other known inducers of hepatic CYP2A5, including cobaltous chloride, stannous chloride, griseofulvin, thioacetamide, and aminotriazole. These results suggest that the mechanisms involved in the induction of hepatic and renal CYP2A5 by pyrazole and other xenobiotic compounds may be tissue-specific.",
author = "Ting Su and Wenlei He and Jun Gu and Lipinskas, {Thomas W.} and Xinxin Ding",
year = "1998",
month = "8",
day = "1",
language = "English (US)",
volume = "26",
pages = "822--824",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "8",

}

TY - JOUR

T1 - Differential xenobiotic induction of CYP2A5 in mouse liver, kidney, lung, and olfactory mucosa

AU - Su, Ting

AU - He, Wenlei

AU - Gu, Jun

AU - Lipinskas, Thomas W.

AU - Ding, Xinxin

PY - 1998/8/1

Y1 - 1998/8/1

N2 - The effects of pyrazole, which is known to induce hepatic cytochrome P4502A5 (CYP2AS) through posttranscriptional mechanisms, on the level of CYP2A5 in liver and extrahepatic tissues were examined in this study. Intraperitoneal administration of pyrazole at 200 mg/kg for 3 days induced CYP2A4/5 mRNAs and proteins and microsomal coumarin 7-hydroxylation activity in liver and kidney of C57BL/6 mice. A marginal increase (30%) in CYP2A4/5 mRNAs was also observed in the olfactory mucosa but not in the lung, and no increase in CYP2A4/5 proteins or microsomal coumarin 7-hydroxylation activity was observed in either the olfactory mucosa or lung. CYP2A4/5 proteins were not detected on immunoblots in other tissues examined, including breast, bone marrow, testis, prostate, ovary, and uterus from control or pyrazole-treated mice. On the other hand, pyrazole treatment induced CYP2E1 in the olfactory mucosa as well as in liver and kidney, indicating that the olfactory mucosa was exposed to pyrazole. The lack of CYP2A inducibility in the olfactory mucosa was also observed for several other known inducers of hepatic CYP2A5, including cobaltous chloride, stannous chloride, griseofulvin, thioacetamide, and aminotriazole. These results suggest that the mechanisms involved in the induction of hepatic and renal CYP2A5 by pyrazole and other xenobiotic compounds may be tissue-specific.

AB - The effects of pyrazole, which is known to induce hepatic cytochrome P4502A5 (CYP2AS) through posttranscriptional mechanisms, on the level of CYP2A5 in liver and extrahepatic tissues were examined in this study. Intraperitoneal administration of pyrazole at 200 mg/kg for 3 days induced CYP2A4/5 mRNAs and proteins and microsomal coumarin 7-hydroxylation activity in liver and kidney of C57BL/6 mice. A marginal increase (30%) in CYP2A4/5 mRNAs was also observed in the olfactory mucosa but not in the lung, and no increase in CYP2A4/5 proteins or microsomal coumarin 7-hydroxylation activity was observed in either the olfactory mucosa or lung. CYP2A4/5 proteins were not detected on immunoblots in other tissues examined, including breast, bone marrow, testis, prostate, ovary, and uterus from control or pyrazole-treated mice. On the other hand, pyrazole treatment induced CYP2E1 in the olfactory mucosa as well as in liver and kidney, indicating that the olfactory mucosa was exposed to pyrazole. The lack of CYP2A inducibility in the olfactory mucosa was also observed for several other known inducers of hepatic CYP2A5, including cobaltous chloride, stannous chloride, griseofulvin, thioacetamide, and aminotriazole. These results suggest that the mechanisms involved in the induction of hepatic and renal CYP2A5 by pyrazole and other xenobiotic compounds may be tissue-specific.

UR - http://www.scopus.com/inward/record.url?scp=0031815726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031815726&partnerID=8YFLogxK

M3 - Article

C2 - 9698299

AN - SCOPUS:0031815726

VL - 26

SP - 822

EP - 824

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 8

ER -